Home Applications 079013 Application 079013
Type ANDA
Sponsor APOTEX INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 ALFUZOSIN HYDROCHLORIDE ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 10MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A079013-001 ALFUZOSIN HYDROCHLORIDE ALFUZOSIN HYDROCHLORIDE 10MG TABLET, EXTENDED RELEASE / ORAL AB 2011-07-18
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A079013-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 A079013-001 ALFUZOSIN HYDROCHLORIDE 10MG TABLET, EXTENDED RELEASE / ORAL AB 2011-07-18 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A079013-001 ALFUZOSIN HYDROCHLORIDE 10MG TABLET, EXTENDED RELEASE / ORAL AB 2011-07-18 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A079013-001 ALFUZOSIN HYDROCHLORIDE 10MG TABLET, EXTENDED RELEASE / ORAL AB 2011-07-18 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A079013-001 ALFUZOSIN HYDROCHLORIDE 10MG TABLET, EXTENDED RELEASE / ORAL AB 2011-07-18 a50c72e98297…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 44 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 4 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 42291-110 Alfuzosin Hydrochloride Alfuzosin Hydrochloride AvKARE, Inc. ANDA Current 60505-2850 Alfuzosin Hydrochloride Alfuzosin Hydrochloride Apotex Corp. ANDA Current 60505-2850 Alfuzosin Hydrochloride Alfuzosin Hydrochloride Apotex Corp. ANDA Current 60505-2850 Alfuzosin Hydrochloride Alfuzosin Hydrochloride Apotex Corp. ANDA Current
Documents# Document, Submission type, Date table Document Submission type Date 31403 ORIG 2011-07-20